BioCentury
ARTICLE | Company News

Valeant Pharmaceuticals sales and marketing update

September 12, 2016 7:00 AM UTC

Valeant launched an oral formulation of Relistor methylnaltrexone in the U.S. to treat opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain. The wholesale acquisition cost...